GSA Capital Partners LLP Takes $926,000 Position in Aehr Test Systems $AEHR

GSA Capital Partners LLP purchased a new position in Aehr Test Systems (NASDAQ:AEHRFree Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 9,639 shares of the semiconductor company’s stock, valued at approximately $926,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Aehr Test Systems by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 2,337,433 shares of the semiconductor company’s stock valued at $47,193,000 after buying an additional 49,243 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Aehr Test Systems by 129.9% in the 4th quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after acquiring an additional 469,400 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Aehr Test Systems by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 685,694 shares of the semiconductor company’s stock worth $13,846,000 after purchasing an additional 5,591 shares during the period. Halter Ferguson Financial Inc. lifted its holdings in shares of Aehr Test Systems by 41.7% during the fourth quarter. Halter Ferguson Financial Inc. now owns 642,129 shares of the semiconductor company’s stock valued at $12,965,000 after purchasing an additional 189,117 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Aehr Test Systems by 3.7% during the fourth quarter. State Street Corp now owns 624,085 shares of the semiconductor company’s stock valued at $12,600,000 after purchasing an additional 21,982 shares during the last quarter. 69.69% of the stock is currently owned by institutional investors.

Insider Transactions at Aehr Test Systems

In other news, Director Laura Oliphant sold 1,717 shares of the firm’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $133.00, for a total transaction of $228,361.00. Following the transaction, the director owned 16,100 shares in the company, valued at approximately $2,141,300. This trade represents a 9.64% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard T. Slayen sold 5,700 shares of Aehr Test Systems stock in a transaction on Friday, August 14th. The shares were sold at an average price of $133.03, for a total transaction of $758,271.00. Following the completion of the sale, the director directly owned 140,667 shares of the company’s stock, valued at approximately $18,712,931.01. The trade was a 3.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 109,475 shares of company stock valued at $13,827,160. Insiders own 6.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on AEHR shares. Jefferies Financial Group started coverage on Aehr Test Systems in a research note on Thursday, August 13th. They issued a “buy” rating and a $175.00 price target on the stock. Weiss Ratings downgraded shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research report on Wednesday, July 29th. Freedom Capital upgraded shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Craig Hallum restated a “buy” rating and issued a $125.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Finally, Lake Street Capital reaffirmed a “buy” rating and issued a $110.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $136.67.

Get Our Latest Stock Analysis on Aehr Test Systems

Aehr Test Systems Price Performance

Shares of AEHR stock opened at $123.25 on Wednesday. Aehr Test Systems has a fifty-two week low of $16.38 and a fifty-two week high of $147.40. The stock’s 50-day moving average is $94.41 and its two-hundred day moving average is $73.26. The firm has a market cap of $4.02 billion, a P/E ratio of -513.52 and a beta of 3.10.

Aehr Test Systems Profile

(Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Featured Stories

Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHRFree Report).

Institutional Ownership by Quarter for Aehr Test Systems (NASDAQ:AEHR)

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.